story of the week
Risk of Hepatitis B Virus Reactivation in People With MS Treated With Ocrelizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey
J Neurol 2024 Apr 05;[EPub Ahead of Print], M Çelik, C Baba, Ç Irmak, S Özakbaş, V Avkan-OğuzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.